These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
263 related articles for article (PubMed ID: 36596674)
1. Clinical characteristics of mpox infection in individuals who received a first dose of modified vaccinia Ankara immunisation. Agunbiade S; Burton F; Muirhead J; Whitlock GG; Girometti N Sex Transm Infect; 2023 May; 99(3):198-199. PubMed ID: 36596674 [TBL] [Abstract][Full Text] [Related]
2. Early evaluation of the safety, reactogenicity, and immune response after a single dose of modified vaccinia Ankara-Bavaria Nordic vaccine against mpox in children: a national outbreak response. Ladhani SN; Dowell AC; Jones S; Hicks B; Rowe C; Begum J; Wailblinger D; Wright J; Owens S; Pickering A; Shilltoe B; McMaster P; Whittaker E; Zuo J; Powell A; Amirthalingam G; Mandal S; Lopez-Bernal J; Ramsay ME; Kissane N; Bell M; Watson H; Ho D; Hallis B; Otter A; Moss P; Cohen J Lancet Infect Dis; 2023 Sep; 23(9):1042-1050. PubMed ID: 37336224 [TBL] [Abstract][Full Text] [Related]
3. Effectiveness of Modified Vaccinia Ankara-Bavaria Nordic Vaccination in a Population at High Risk of Mpox: A Spanish Cohort Study. Fontán-Vela M; Hernando V; Olmedo C; Coma E; Martínez M; Moreno-Perez D; Lorusso N; Vázquez Torres M; Barbas Del Buey JF; Roig-Sena J; Pastor E; Galmés Truyols A; Artigues Serra F; Sancho Martínez RM; Latasa Zamalloa P; Pérez Martínez O; Vázquez Estepa A; García Rojas AJ; Barreno Estévez AI; Sánchez-Migallón Naranjo A; Pérez Martín JJ; Peces Jiménez P; Morales Romero R; Castilla J; García Cenoz M; Huerta Huerta M; Boone ALD; Macías Ortiz MJ; Álvarez Río V; Rodríguez Recio MJ; Merino Díaz M; Berradre Sáenz B; Villegas-Moreno MT; Limia A; Diaz A; Monge S; Clin Infect Dis; 2024 Feb; 78(2):476-483. PubMed ID: 37864849 [TBL] [Abstract][Full Text] [Related]
4. Effectiveness of one dose of MVA-BN smallpox vaccine against mpox in England using the case-coverage method: an observational study. Bertran M; Andrews N; Davison C; Dugbazah B; Boateng J; Lunt R; Hardstaff J; Green M; Blomquist P; Turner C; Mohammed H; Cordery R; Mandal S; Campbell C; Ladhani SN; Ramsay M; Amirthalingam G; Bernal JL Lancet Infect Dis; 2023 Jul; 23(7):828-835. PubMed ID: 36924787 [TBL] [Abstract][Full Text] [Related]
5. Outcomes of post-exposure vaccination by modified vaccinia Ankara to prevent mpox (formerly monkeypox): a retrospective observational study in Lyon, France, June to August 2022. Merad Y; Gaymard A; Cotte L; Perpoint T; Alfaiate D; Godinot M; Becker A; Cannesson O; Batalla AS; Oria-Yassir F; Landré S; Morfin F; Bouscambert M; Valour F; Ader F; Conrad A Euro Surveill; 2022 Dec; 27(50):. PubMed ID: 36695469 [TBL] [Abstract][Full Text] [Related]
6. Prospective monitoring of adverse events following vaccination with Modified vaccinia Ankara - Bavarian Nordic (MVA-BN) administered to a Canadian population at risk of Mpox: A Canadian Immunization Research Network study. Muller MP; Navarro C; Wilson SE; Shulha HP; Naus M; Lim G; Padhi S; McGeer A; Finkelstein M; Liddy A; Bettinger JA; Vaccine; 2024 Jan; 42(3):535-540. PubMed ID: 38199921 [TBL] [Abstract][Full Text] [Related]
8. Mpox in people with past infection or a complete vaccination course: a global case series. Hazra A; Zucker J; Bell E; Flores J; Gordon L; Mitjà O; Suñer C; Lemaignen A; Jamard S; Nozza S; Nori AV; Pérez-Barragán E; Rodríguez-Aldama JC; Blanco JL; Delaugerre C; Turner D; Fuertes I; Leiro V; Walmsley SL; Orkin CM; Lancet Infect Dis; 2024 Jan; 24(1):57-64. PubMed ID: 37678309 [TBL] [Abstract][Full Text] [Related]
9. Asymptomatic and Subclinical Mpox: An Association With Modified Vaccinia Ankara Vaccine. Golden MR; Soge OO; Mills M; Berzkalns A; Cannon C; Ramchandani M; Dombrowski JC; Karmarkar EN; Chow EJ; Gov JP; Swenson P; Greninger AL Sex Transm Dis; 2024 May; 51(5):342-347. PubMed ID: 38301634 [TBL] [Abstract][Full Text] [Related]
10. Uptake of Mpox vaccination among transgender people and gay, bisexual and other men who have sex with men among sexually-transmitted infection clinic clients in Vancouver, British Columbia. Gilbert M; Ablona A; Chang HJ; Grennan T; Irvine MA; Sarai Racey C; Salway T; Naus M; Dawar M; Ogilvie G Vaccine; 2023 Apr; 41(15):2485-2494. PubMed ID: 36894397 [TBL] [Abstract][Full Text] [Related]
11. Estimated Effectiveness of JYNNEOS Vaccine in Preventing Mpox: A Multijurisdictional Case-Control Study - United States, August 19, 2022-March 31, 2023. Dalton AF; Diallo AO; Chard AN; Moulia DL; Deputy NP; Fothergill A; Kracalik I; Wegner CW; Markus TM; Pathela P; Still WL; Hawkins S; Mangla AT; Ravi N; Licherdell E; Britton A; Lynfield R; Sutton M; Hansen AP; Betancourt GS; Rowlands JV; Chai SJ; Fisher R; Danza P; Farley M; Zipprich J; Prahl G; Wendel KA; Niccolai L; Castilho JL; Payne DC; Cohn AC; Feldstein LR; ; MMWR Morb Mortal Wkly Rep; 2023 May; 72(20):553-558. PubMed ID: 37200229 [TBL] [Abstract][Full Text] [Related]
12. Case study: breakthrough mpox infection in Aotearoa New Zealand and Australia after completed two-dose course of subcutaneous modified vaccinia Ankara (MVA-BN) vaccines. Cornelisse VJ; Kearley JJM; Vargas Castillo J; Macharg L; McLaughlin VA; Jack SJ; Swift C Sex Health; 2023 Dec; 20(6):585-587. PubMed ID: 37852607 [TBL] [Abstract][Full Text] [Related]
13. Human Monkeypox Experience in a Tertiary Level Hospital in Milan, Italy, between May and October 2022: Epidemiological Features and Clinical Characteristics. Candela C; Raccagni AR; Bruzzesi E; Bertoni C; Rizzo A; Gagliardi G; Canetti D; Gianotti N; Mileto D; Gismondo MR; Castagna A; Nozza S; Viruses; 2023 Mar; 15(3):. PubMed ID: 36992376 [TBL] [Abstract][Full Text] [Related]
14. Effectiveness of JYNNEOS Vaccine Against Diagnosed Mpox Infection - New York, 2022. Rosenberg ES; Dorabawila V; Hart-Malloy R; Anderson BJ; Miranda W; O'Donnell T; Gonzalez CJ; Abrego M; DelBarba C; Tice CJ; McGarry C; Mitchell EC; Boulais M; Backenson B; Kharfen M; McDonald J; Bauer UE MMWR Morb Mortal Wkly Rep; 2023 May; 72(20):559-563. PubMed ID: 37339074 [TBL] [Abstract][Full Text] [Related]
15. Reduced Risk for Mpox After Receipt of 1 or 2 Doses of JYNNEOS Vaccine Compared with Risk Among Unvaccinated Persons - 43 U.S. Jurisdictions, July 31-October 1, 2022. Payne AB; Ray LC; Cole MM; Canning M; Houck K; Shah HJ; Farrar JL; Lewis NM; Fothergill A; White EB; Feldstein LR; Roper LE; Lee F; Kriss JL; Sims E; Spicknall IH; Nakazawa Y; Gundlapalli AV; Shimabukuro T; Cohen AL; Honein MA; Mermin J; Payne DC MMWR Morb Mortal Wkly Rep; 2022 Dec; 71(49):1560-1564. PubMed ID: 36480479 [TBL] [Abstract][Full Text] [Related]
16. Impact of vaccination with third generation modified vaccinia Ankara and sexual behaviour on mpox incidence in men who have sex with men: analysis among participants of the ANRS-174 DOXYVAC trial. Ghosn J; Assoumou L; Ouattara M; Rubenstein E; Pialoux G; Katlama C; Surgers L; Duvivier C; Pavie J; Viard JP; Algarte-Genin M; Gibowski S; Ollivier M; Costagliola D; Molina JM Lancet Reg Health Eur; 2024 Oct; 45():101020. PubMed ID: 39188858 [TBL] [Abstract][Full Text] [Related]
17. Vaccines against mpox: MVA-BN and LC16m8. Grabenstein JD; Hacker A Expert Rev Vaccines; 2024; 23(1):796-811. PubMed ID: 39188013 [TBL] [Abstract][Full Text] [Related]
18. Real-world effectiveness of a single dose of mpox vaccine in males. Wolff Sagy Y; Zucker R; Hammerman A; Markovits H; Arieh NG; Abu Ahmad W; Battat E; Ramot N; Carmeli G; Mark-Amir A; Wagner-Kolasko G; Duskin-Bitan H; Yaron S; Peretz A; Arbel R; Lavie G; Netzer D Nat Med; 2023 Mar; 29(3):748-752. PubMed ID: 36720271 [TBL] [Abstract][Full Text] [Related]
19. Effectiveness of modified vaccinia Ankara-Bavarian Nordic vaccine against mpox infection: emulation of a target trial. Navarro C; Lau C; Buchan SA; Burchell AN; Nasreen S; Friedman L; Okpokoro E; Austin PC; Tan DHS; Gubbay JB; Kwong JC; Mishra S; BMJ; 2024 Sep; 386():e078243. PubMed ID: 39260880 [TBL] [Abstract][Full Text] [Related]
20. Characterizing the acute antibody response of monkeypox and MVA-BN vaccine following an Australian outbreak. Asquith W; Hueston L; Dwyer D; Kok J; Ko D; Fennel M; Rockett R; Rai NJ; Li Y; Sriramoju S; Sutor A; O'Sullivan M J Med Virol; 2024 Jan; 96(1):e29407. PubMed ID: 38240403 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]